Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs (VEINSFORLIFE)

C. R. Bard

Status: Completed

Conditions: PORTs/Peripheral IVs Complication Rates

Study type: Observational

Funder types: Industry

Identifiers

NCT02792764

BPV-13-003

Details and patient eligibility

About

This study is to collect current information on complications rates of subjects undergoing chemotherapy administration through Ports and peripheral IVs.

Enrollment: 300 patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female, age ≥ 21 years
• Subject is currently undergoing or has had infusional cancer therapy (solid tumor or hematologic) through a Bard PORT with a distally-valved catheter/open-ended catheter or infusion through a PIV
• Subject had a chemotherapy regimen consisting of a vesicant and/or irritant
• Subject has signed an Informed Consent Form (ICF) or has had an ICF signed by the subject's legally authorized representative

Exclusion criteria

• Subject has/had an implanted non Bard PORT

Trial design

300 participants in 2 patient groups

Port

Description:

Subjects receiving chemotherapy through a port

Peripheral Intravenous (PIV) Lines

Description:

Subjects receiving chemotherapy through a peripheral IV